Published Date: 13 Nov 2025
For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms—pain in her spine and hips, nausea, exhaustion, thirst, and frequent urination. Her primary care physician had ruled out diabetes before finally ...
Read Full News1.
Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC
2.
Stevia leaf extract has potential as anticancer treatment, researchers find
3.
Combination therapy improves outcomes for advanced triple-negative breast cancer
4.
An understudied type of breast cancer poses a lurking threat
5.
According to a study, there is now a 94 percent survival rate for children with acute lymphatic leukemia.
1.
Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment
2.
Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers
3.
Integrated Perspectives in Oncology in Clinical Decision-Making
4.
The Importance of Balanced Potassium Levels in Maintaining Good Health
5.
Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation